EN
HI
Summary
As of 10 Sep, 2026, Thyrocare Technologies stock price is ₹557.95. During the trading session, the stock has moved between an intraday low of ₹553.65 and an intraday high of ₹569.55. Over the last 52 weeks, Thyrocare Technologies has traded between ₹342.55 and ₹662.00.
The stock has recorded a trading volume of 2,25,869 shares,. Its Average Traded Price (ATP) is ₹559.45, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹557.95.
Thyrocare Technologies has an upper circuit limit of ₹680.20 and a lower circuit limit of ₹453.50. The total value traded stands at ₹12.64 CR, and the delivery percentage for the day is 53.48%.
The stock is currently traded with a market lot size of 1. Thyrocare Technologies also offers a dividend yield of 2.47%.
Thyrocare Technologies Share Price Chart
Thyrocare Technologies Share Key Metrics
Volume
2.26 L
Market Cap
9022.29 CR
LTQ@LTP
3@557.95
ATP
559.45
Var Margin
19.9 %
Circuit Range
453.5-680.2
Delivery %
53.48 %
Value
12.64 CR
ASM/GSM
No
Market Lot
1
Thyrocare Technologies Fundamentals
P/E Ratio
51.24
P/B Ratio
14.35
Div. Yield
2.47
Sector P/E
57.33
Sector P/B
-13.42
Sec. Div. Yield
0.16
Thyrocare Technologies Resistance and Support
Pivot 568.33
Resistance
First Resistance
572.56
Second Resistance
578.28
Third Resistance
582.51
Support
First Support
562.61
Second Support
558.38
Third Support
552.66
Thyrocare Technologies Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Sep 10 2026 | 568.9 | 557.95 | -1.57% | 569.55 | 553.65 |
| Wed Sep 09 2026 | 569.45 | 566.84 | -0.46% | 574.04 | 564.09 |
| Tue Sep 08 2026 | 573.09 | 569.45 | -0.65% | 577 | 566.59 |
Thyrocare Technologies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-23 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-01-28 | Quarterly Results |
| 2025-10-14 | Qtr Results |
| 2025-07-23 | Quarterly Results |
| 2025-04-23 | Audited Results & Final Dividend |
| 2025-01-23 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
Thyrocare Technologies News
Thyrocare Technologies Ltd - 539871 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
API Holdings, the successor entity to erstwhile promoter Docon Technologies, released a pledge on 7.94 crore equity shares of Thyrocare Technologies. This represents 49.93% of Thyrocare's total share capital, previously securing NCDs worth Rs.1,050 crore which were repaid.
Sep 09 2026 12:22:42
Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
API Holdings acquired a 51.02% stake in Thyrocare Technologies Limited by operation of law following the NCLT-sanctioned amalgamation of Docon Technologies Private Limited with API Holdings. The transaction was effective September 03, 2026.
Sep 04 2026 16:30:27
Read More
Thyrocare Technologies Management
| Name | Position |
|---|---|
| Brijesh Kumar | Company Secretary & Compliance Officer |
| Rahul Guha | Chairman, Managing Director & Chief Executive Officer |
Thyrocare Technologies Similar Stocks
Suven Life Sciences Ltd.
360.85
3.35 (0.94%)
Healthcare Global Enterprises Ltd.
701.50
-11.05 (1.55%)
Yatharth Hospital & Trauma Care Services Ltd.
987.00
-2.70 (0.27%)
Jupiter Life Line Hospitals Ltd.
281.30
-0.70 (0.25%)
Procter & Gamble Health Ltd.
5437.50
-37.50 (0.68%)
Aarti Pharmalabs Ltd.
819.25
-10.40 (1.25%)
Bliss GVS Pharma Ltd.
702.90
10.05 (1.45%)
Nephrocare Health Services Ltd.
747.20
13.75 (1.87%)
Sanofi India Ltd.
3103.70
-0.50 (0.02%)
Thyrocare Technologies FAQs
The Buying Price of Thyrocare Technologies share is 557.95 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Thyrocare Technologies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Thyrocare Technologies, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Thyrocare Technologies shares is 51.24. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Thyrocare Technologies shares is 14.35. Useful to assess the stock's value relative to its book value.
To assess Thyrocare Technologies’s valuation compare Sector P/E, P/B which are 57.33 & -13.42 with sector averages, along with growth rates and financial metrics.
The Market Cap of Thyrocare Technologies is 9022.29 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Thyrocare Technologies share price is 662.00 & 342.55. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Thyrocare Technologies belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in THYROCARE
